Filtered By:
Condition: Heart Attack
Procedure: Coronary Artery Bypass Graft

This page shows you your search results in order of date. This is page number 4.

Order by Relevance | Date

Total 1114 results found since Jan 2013.

Implications of left atrial volume index in patients with three-vessel coronary disease: A 6.6-year follow-up cohort study
CONCLUSIONS: LAVI is a potential index for risk stratification and therapeutic decision-making in patients with three-vessel coronary disease. CABG is associated with improved long-term outcomes compared with MT alone, regardless of LAVI quartiles. When LAVI is severely elevated, PCI is associated with higher risk of cardiac death than CABG.PMID:37262047 | DOI:10.1097/CM9.0000000000002723
Source: Chinese Medical Journal - June 1, 2023 Category: General Medicine Authors: Ru Liu Lei Song Ce Zhang Lin Jiang Jian Tian Lianjun Xu Xinxing Feng Linyuan Wan Xueyan Zhao Ou Xu Chongjian Li Runlin Gao Rutai Hui Wei Zhao Jinqing Yuan Source Type: research

Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes: A Pooled Analysis of 4 Randomized Clinical Trials
CONCLUSION AND RELEVANCE: Among largely stable patients undergoing left main revascularization and with predominantly low to intermediate coronary anatomical complexity, those with ACS had higher rates of early death. Nonetheless, rates of all-cause mortality through 5 years were similar with PCI vs CABG in this high-risk subgroup. The relative advantages and disadvantages of PCI vs CABG in terms of early stroke and long-term spontaneous MI and repeat revascularization were consistent regardless of ACS status.TRIAL REGISTRATION: ClinicalTrials.gov Identifiers: NCT00114972, NCT00422968, NCT01496651, NCT01205776.PMID:3725659...
Source: Atherosclerosis - May 31, 2023 Category: Cardiology Authors: Prakriti Gaba Evald H Christiansen Per H Nielsen Sabina A Murphy Patrick T O'Gara Peter K Smith Patrick W Serruys A Pieter Kappetein Seung-Jung Park Duk-Woo Park Gregg W Stone Joseph F Sabik Marc S Sabatine Niels R Holm Brian A Bergmark Source Type: research

Minimally invasive strategies of surgical coronary artery revascularization for the aging population
CONCLUSIONS: MICS-CABG grafting is associated with excellent early and long-term outcomes in eligible octogenarians.PMID:37255493 | DOI:10.23736/S0021-9509.23.12621-8
Source: The Journal of Cardiovascular Surgery - May 31, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Magdalena I Rufa Adrian Ursulescu Dincer Aktuerk Ragi Nagib Marc Albert Nora G öbel Tunjay Shavahatli Ulrich F Franke Source Type: research

Association between preoperative blood pressure and outcomes in cardiac surgery: results of a prospectively planned cohort study
CONCLUSIONS: High preoperative BP measured by ABP monitoring is a risk factor for postoperative complications in patients submitted to CABG.PMID:37255492 | DOI:10.23736/S0021-9509.23.12581-X
Source: The Journal of Cardiovascular Surgery - May 31, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Lucas Molinari Veloso da Silveira Sandra Costa Fuchs Gabriela Brendel Blum Leonardo Grabinski Bottino Fl ávio Danni Fuchs Source Type: research

Atorvastatin and the influence on postoperative atrial fibrillation after surgical aortic valve replacement (STARC) in adults at Odense University Hospital, Denmark: study protocol for a randomised controlled trial
Introduction Atrial fibrillation (AF) is the most common postoperative complication after surgical aortic valve replacement (SAVR) and occurs in up to 50% of the patients. Development of postoperative AF (POAF) is associated with a 2–3 fold increased risk of adverse events, including stroke, myocardial infarction and death. Several studies have implied that prophylactic Atorvastatin therapy could prevent POAF in patients undergoing coronary artery bypass graft. These studies suggest that Atorvastatin has rapid and significant pleiotropic actions that reduce the risk of POAF. However, prophylactic treatment with stati...
Source: BMJ Open - May 10, 2023 Category: General Medicine Authors: Krasniqi, L., Brandes, A., Mortensen, P. E., Dahl, J. S., Gerke, O., Ali, M., Riber, L. P. S. Tags: Open access, Cardiovascular medicine Source Type: research

Patients with higher-atherothrombotic risk vs. lower-atherothrombotic risk undergoing coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials
ConclusionIn the era of newer-generation DES, patients with H-ATR still are at hazard for ischemic events. Patients with BP-SES had lower TLF rates as compared with DP-EES, most consistent in L-ATR whereas in H-ATR patients most probably secondary preventive strategies are of higher value.Clinical trial registrationClinicaltrial.gov. NCT01356888, NCT01939249, NCT02389946.https://clinicaltrials.gov/show/NCT01356888,https://clinicaltrials.gov/show/NCT01939249,https://clinicaltrials.gov/show/NCT02389946.Graphical abstract
Source: Clinical Research in Cardiology - April 16, 2023 Category: Cardiology Source Type: research

Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome
CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066
Source: Polish Heart Journal - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research